StockData
Roivant Sciences Ltd. logo

Roivant Sciences Ltd. (ROIV) stock

ROIVNasdaqPharmaceutical PreparationsFiscal year ends March 31
Financials through Q1 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$38.71+0.10 (+0.26%)

Close on Nov 17, 2026Market cap $27.96BP/E –Yield –

Roivant Sciences price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Roivant Sciences's price to book ratio was 7.1× on Nov 11, 2026, against 3.3× a year earlier. Over the last 5 years it ranged from 1.4× to 9.8×, with a median of 3.1×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20267.1×+3.7
2025Dec 31, 20253.4×+1.7
2024Dec 31, 20241.7×−7.8
2023Dec 29, 20239.5×+4.6
2022Dec 30, 20224.8×+1.5
2021Dec 31, 20213.4×–

More Roivant Sciences figures

See a number that looks wrong?